Glimepiride

CAS 93479-97-1 18 current records 5 historicalSmall Molecule

Who holds supplier records for Glimepiride? 18 organisations hold a current record for Glimepiride: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 16 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), China (4), Germany (1), Italy (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Glimepiride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/glimepiride

Reading the evidence

  • 18 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 13 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (18)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Glimepiride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India10China4Germany1Italy1South Korea1Country not recorded for 1
Need Glimepiride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (16)

Certificates of Suitability on the EDQM register for Glimepiride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
USV PRIVATE LIMITED MumbaiIN
CEP 2023-130 - Rev 02
Glimepiride, Micronised
Jun 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2006-172 - Rev 05
Glimepiride
May 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2007-156 - Rev 05
Glimepiride
Mar 2026—
SHANDONG XINHUA PHARMACEUTICAL CO., LTD. ZiboCN
CEP 2023-111 - Rev 00
Glimepiride
Dec 2025Inspected Nov 2025
Hungary
MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor VillageIN
CEP 2022-111 - Rev 01
Glimepiride
Aug 2025—
MEDILUX LABORATORIES PRIVATE LIMITED PithampurIN
CEP 2024-154 - Rev 00
Glimepiride
Nov 2024Inspected Nov 2025
Germany
MICRO LABS LIMITED BengaluruIN
CEP 2022-357 - Rev 00
Glimepiride
Sept 2024—
INDOCO REMEDIES LIMITED MumbaiIN
CEP 2009-067 - Rev 04
Glimepiride
Feb 2024—
EUROAPI GERMANY GmbH Frankfurt am MainDE
R0-CEP 2022-234 - Rev 00
Glimepiride, Process 2
Oct 2022—
URQUIMA S.A. Palau-solità i PlegamansES
R1-CEP 2007-017 - Rev 03
Glimepiride
Jun 2022—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2008-072 - Rev 05
Glimepiride
Mar 2022—
IPCA Laboratories Limited MumbaiIN
R1-CEP 2007-036 - Rev 01
Glimepiride
Dec 2019—
INIST ST CO., LTD. Eumseong-gunKR
R1-CEP 2006-202 - Rev 02
Glimepiride
Feb 2016—
EDMOND PHARMA S.R.L. Paderno DugnanoIT
R1-CEP 2007-180 - Rev 01
Glimepiride
Apr 2015—
Chongqing Carelife Pharmaceutical Co. Ltd. ChongqingCN
R1-CEP 2007-035 - Rev 00
Glimepiride, Micropowder and super micropowder
May 2014—
Nexchem Pharmaceutical Co., Ltd. Jinhua CityCN
R1-CEP 2006-311 - Rev 00
Glimepiride
Jan 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Glimepiride are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Overview

Glimepiride is a sulfonylurea class antidiabetic medication used to treat type 2 diabetes mellitus. It helps control blood sugar levels by stimulating insulin release from pancreatic beta cells.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Sulfonylurea
Chemical structure
Sulfonylurea Compounds

Therapeutic areas

EndocrinologyDiabetes

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Glimepiride?

18 organisations hold an active US FDA Type II Drug Master File or a CEP for Glimepiride: SHANDONG XINHUA PHARMACEUTICAL CO LTD (China), ALIVUS LIFE SCIENCES LTD (India), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Dr. Reddy's Laboratories Ltd. (India), EUROAPI GERMANY GMBH (Germany), Hetero Drugs Limited (India), INDOCO REMEDIES LTD (India) and Ipca Laboratories Limited (India), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Glimepiride Drug Master Files are active?

SHANDONG XINHUA PHARMACEUTICAL CO LTD (DMF 40322, 32319), ALIVUS LIFE SCIENCES LTD (DMF 17594), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 15882), Dr. Reddy's Laboratories Ltd. (DMF 16983), EUROAPI GERMANY GMBH (DMF 37318), Hetero Drugs Limited (DMF 17656), INDOCO REMEDIES LTD (DMF 22565) and Ipca Laboratories Limited (DMF 20037) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Glimepiride records mean?

5 organisations have only inactive Type II DMFs for Glimepiride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Glimepiride have a European Certificate of Suitability?

Yes. 16 organisations hold a valid CEP for Glimepiride on the EDQM register, including USV PRIVATE LIMITED Mumbai (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), HETERO DRUGS LIMITED Hyderabad (IN), SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo (CN), MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village (IN) and MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN) and 10 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Glimepiride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Glimepiride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.